See more : Green Technology Metals Limited (GT1.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Charles & Colvard, Ltd. (CTHR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Charles & Colvard, Ltd., a leading company in the Luxury Goods industry within the Consumer Cyclical sector.
You may be interested
- PeakBirch Commerce Inc. (PKBFF) Income Statement Analysis – Financial Results
- Showa Denko K.K. (4004.T) Income Statement Analysis – Financial Results
- Flowing Cloud Technology Ltd (6610.HK) Income Statement Analysis – Financial Results
- TVS Srichakra Limited (TVSSRICHAK.NS) Income Statement Analysis – Financial Results
- NS Solutions Corporation (NSSXF) Income Statement Analysis – Financial Results
Charles & Colvard, Ltd. (CTHR)
About Charles & Colvard, Ltd.
Charles & Colvard, Ltd. operates as a fine jewelry company in the United States and internationally. The company manufactures, markets, and distributes moissanite jewels and finished moissanite jewelry under the Charles & Colvard Created Moissanite brand; and premium moissanite gemstones under the Forever One brand name. It also markets and distributes lab grown diamonds, and finished jewelry with lab grown diamonds under the Caydia brand. The company sells its products at wholesale prices to distributors, manufacturers, retailers, and designers; and to end-consumers at retail prices through charlesandcolvard.com, third-party online marketplaces, drop-ship, and other e-commerce outlets. Charles & Colvard, Ltd. was founded in 1995 and is headquartered in Morrisville, North Carolina.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 29.95M | 43.09M | 39.24M | 29.19M | 32.24M | 27.03M | 29.17M | 30.77M | 25.64M | 28.49M | 22.41M | 16.03M | 12.69M | 8.31M | 14.73M | 27.82M | 40.71M | 43.54M | 23.92M | 17.24M | 16.51M | 11.51M | 12.80M | 12.30M | 4.00M | 100.00K | 100.00K |
| Cost of Revenue | 25.21M | 22.85M | 20.81M | 21.20M | 17.35M | 15.47M | 20.40M | 20.55M | 18.01M | 14.60M | 9.96M | 6.51M | 4.83M | 3.47M | 5.59M | 7.61M | 10.80M | 14.46M | 8.57M | 6.58M | 6.59M | 5.14M | 5.26M | 5.70M | 2.70M | 0.00 | 0.00 |
| Gross Profit | 4.73M | 20.24M | 18.43M | 7.99M | 14.89M | 11.56M | 8.77M | 10.21M | 7.63M | 13.89M | 12.45M | 9.52M | 7.86M | 4.84M | 9.13M | 20.21M | 29.92M | 29.08M | 15.35M | 10.66M | 9.93M | 6.37M | 7.54M | 6.60M | 1.30M | 100.00K | 100.00K |
| Gross Profit Ratio | 15.81% | 46.98% | 46.96% | 27.37% | 46.19% | 42.77% | 30.06% | 33.20% | 29.75% | 48.75% | 55.56% | 59.39% | 61.96% | 58.22% | 62.02% | 72.65% | 73.48% | 66.78% | 64.17% | 61.86% | 60.11% | 55.34% | 58.90% | 53.66% | 32.50% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 2.07K | 3.71K | 2.85K | 17.80K | 18.07K | 24.90K | 17.01K | 145.72K | 99.89K | 401.50K | 113.62K | 76.65K | 73.23K | 215.78K | 14.08K | 26.70K | 7.26K | 21.98K | 1.44M | 2.70M | 4.00M | 2.10M | 200.00K |
| General & Administrative | 5.02M | 4.95M | 4.44M | 4.86M | 4.64M | 4.69M | 5.54M | 7.38M | 6.79M | 5.48M | 4.76M | 4.67M | 4.53M | 5.70M | 15.92M | 19.81M | 20.41M | 19.74M | 12.29M | 8.54M | 7.37M | 5.33M | 12.72M | 9.40M | 5.70M | 3.30M | 200.00K |
| Selling & Marketing | 13.69M | 12.42M | 8.48M | 9.44M | 7.98M | 7.48M | 7.04M | 12.36M | 9.85M | 9.87M | 7.44M | 3.31M | 1.99M | 1.95M | 7.47M | 14.09M | 16.11M | 15.57M | 9.29M | 6.08M | 4.97M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 18.71M | 17.37M | 12.92M | 14.30M | 12.62M | 12.17M | 12.58M | 19.75M | 16.64M | 15.34M | 12.20M | 7.98M | 6.52M | 7.65M | 15.92M | 19.81M | 20.41M | 19.74M | 12.29M | 8.54M | 7.37M | 5.33M | 12.72M | 9.40M | 5.70M | 3.30M | 200.00K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -13.00 | 0.00 | 20.40M | 0.00 | 0.00 | 0.00 | 0.00 | 94.41K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -450.00 | 119.46K | 569.99K | 700.00K | 200.00K | 0.00 | 0.00 |
| Operating Expenses | 18.71M | 17.37M | 12.92M | 14.30M | 12.63M | 12.17M | 12.59M | 19.76M | 16.66M | 15.37M | 12.22M | 8.22M | 6.62M | 8.05M | 16.03M | 19.88M | 20.49M | 19.95M | 12.31M | 8.57M | 7.38M | 5.47M | 14.73M | 12.80M | 9.90M | 5.40M | 400.00K |
| Cost & Expenses | 43.92M | 40.22M | 33.73M | 35.50M | 29.98M | 27.64M | 32.99M | 40.32M | 34.67M | 29.97M | 22.18M | 14.73M | 11.44M | 11.53M | 21.63M | 27.49M | 31.28M | 34.41M | 20.88M | 15.15M | 13.96M | 10.61M | 19.99M | 18.50M | 12.60M | 5.40M | 400.00K |
| Interest Income | 297.26K | 19.28K | 5.58K | 158.09K | 11.02K | 0.00 | 0.00 | 11.00 | 65.00 | 22.01K | 69.52K | 85.27K | 109.18K | 38.19K | 116.48K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 19.28K | 8.95K | 884.00 | 2.20K | 541.00 | 1.74K | 10.36K | 901.00 | 2.11K | 1.26K | 1.14K | 2.83K | 107.61K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.22M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 653.16K | 479.31K | 567.12K | 490.24K | 481.32K | 422.02K | 557.39K | 863.35K | 1.11M | 862.68K | 608.17K | 299.55K | 136.62K | 168.88K | 216.03K | 200.63K | 188.76K | 247.44K | 197.19K | 161.90K | 128.60K | 150.94K | 569.99K | 700.00K | 200.00K | 400.00K | -100.00K |
| EBITDA | -13.03M | 3.35M | 6.23M | -5.67M | 3.14M | -3.85K | -3.38M | -4.32M | -7.94M | -697.70K | 936.01K | 1.68M | 1.46M | -3.36M | -6.57M | 526.07K | 9.62M | 9.38M | 3.24M | 2.09M | 2.55M | 1.05M | -6.62M | -5.50M | -8.40M | -5.30M | -300.00K |
| EBITDA Ratio | -43.50% | 7.83% | 15.50% | -19.42% | 8.55% | -0.69% | -11.18% | -28.23% | -30.91% | -2.10% | 4.08% | 10.51% | 11.73% | -34.88% | -45.39% | 1.89% | 23.62% | 21.54% | 13.53% | 13.09% | 16.23% | 10.17% | -49.31% | -44.72% | -255.00% | -5,800.00% | -300.00% |
| Operating Income | -13.98M | 2.87M | 5.51M | -6.32M | 2.27M | -608.54K | -3.94M | -9.55M | -9.04M | -1.58M | 234.07K | 1.30M | 1.24M | -3.36M | -6.90M | 325.45K | 9.43M | 9.13M | 3.04M | 2.09M | 2.55M | 899.14K | -7.19M | -6.20M | -8.60M | -5.30M | -300.00K |
| Operating Income Ratio | -46.67% | 6.67% | 14.04% | -21.64% | 7.03% | -2.25% | -13.50% | -31.04% | -35.27% | -5.55% | 1.04% | 8.10% | 9.79% | -40.42% | -46.85% | 1.17% | 23.16% | 20.97% | 12.70% | 12.15% | 15.45% | 7.82% | -56.22% | -50.41% | -215.00% | -5,300.00% | -300.00% |
| Total Other Income/Expenses | 297.26K | 19.24K | 970.35K | 155.38K | 8.47K | 182.68K | -1.74K | -10.22K | -836.00 | 19.90K | 68.26K | 84.85K | 80.82K | 38.19K | 116.48K | 491.14K | 741.16K | 503.76K | 138.22K | 112.36K | 199.08K | 325.60K | 114.54K | 1.00M | 1.80M | 500.00K | -100.00K |
| Income Before Tax | -13.68M | 2.89M | 6.48M | -6.16M | 2.27M | -425.87K | -3.94M | -9.56M | -9.05M | -1.56M | 302.33K | 1.38M | 1.32M | -3.32M | -6.78M | 816.58K | 10.17M | 9.63M | 3.18M | 2.21M | 2.75M | 1.22M | -7.08M | -5.20M | -6.70M | -4.90M | -400.00K |
| Income Before Tax Ratio | -45.68% | 6.71% | 16.51% | -21.11% | 7.05% | -1.58% | -13.50% | -31.07% | -35.28% | -5.48% | 1.35% | 8.63% | 10.43% | -39.96% | -46.06% | 2.94% | 24.98% | 22.12% | 13.28% | 12.80% | 16.66% | 10.65% | -55.32% | -42.28% | -167.50% | -4,900.00% | -400.00% |
| Income Tax Expense | 5.90M | 518.53K | -6.33M | 1.73K | -1.44K | 27.61K | 13.48K | 12.82K | 4.05M | -269.29K | -4.15M | -183.95K | -234.28K | 77.71K | -632.67K | 841.01K | 4.07M | 3.76M | 1.56M | 1.16M | -6.66M | -1.22M | 7.08M | 5.20M | 6.70M | 4.90M | 400.00K |
| Net Income | -19.58M | 2.37M | 12.81M | -6.16M | 2.28M | -453.48K | -4.53M | -9.57M | -13.10M | -1.29M | 4.45M | 1.57M | 1.56M | -3.40M | -6.15M | -24.42K | 6.11M | 5.87M | 1.61M | 1.04M | 9.41M | 1.22M | -7.08M | -5.20M | -6.70M | -4.90M | -400.00K |
| Net Income Ratio | -65.39% | 5.51% | 32.65% | -21.11% | 7.06% | -1.68% | -15.52% | -31.11% | -51.08% | -4.53% | 19.85% | 9.78% | 12.27% | -40.89% | -41.77% | -0.09% | 15.00% | 13.49% | 6.74% | 6.05% | 56.97% | 10.65% | -55.32% | -42.28% | -167.50% | -4,900.00% | -400.00% |
| EPS | -0.64 | 0.08 | 0.44 | -0.22 | 0.10 | -0.02 | -0.22 | -0.47 | -0.65 | -0.06 | 0.23 | 0.08 | 0.08 | -0.18 | -0.34 | 0.00 | 0.34 | 0.33 | 0.09 | 0.06 | 0.53 | 0.08 | -0.75 | -0.56 | -0.73 | -1.31 | -0.15 |
| EPS Diluted | -0.64 | 0.08 | 0.42 | -0.22 | 0.10 | -0.02 | -0.22 | -0.47 | -0.65 | -0.06 | 0.22 | 0.08 | 0.08 | -0.18 | -0.34 | 0.00 | 0.33 | 0.31 | 0.09 | 0.06 | 0.53 | 0.08 | -0.75 | -0.56 | -0.73 | -1.31 | -0.15 |
| Weighted Avg Shares Out | 30.38M | 30.36M | 29.14M | 28.64M | 21.86M | 21.19M | 20.80M | 20.35M | 20.15M | 19.90M | 19.58M | 19.44M | 19.18M | 18.72M | 18.24M | 18.07M | 18.16M | 18.01M | 17.47M | 17.36M | 17.53M | 16.47M | 9.41M | 9.24M | 9.13M | 3.74M | 2.67M |
| Weighted Avg Shares Out (Dil) | 30.38M | 31.32M | 30.23M | 28.64M | 22.11M | 21.19M | 20.93M | 20.41M | 20.30M | 19.90M | 19.97M | 19.70M | 19.42M | 18.72M | 18.24M | 18.07M | 18.66M | 18.96M | 18.01M | 17.78M | 17.91M | 16.48M | 9.41M | 9.24M | 9.13M | 3.74M | 2.67M |
Charles & Colvard Regains Compliance With Nasdaq Minimum Bid Price Listing Requirement
RESEARCH TRIANGLE PARK, N.C., Dec. 1, 2020 /PRNewswire/ -- Charles & Colvard, Ltd. (Nasdaq: CTHR) (the "Company"), a globally recognized lab created gemstone company specializing in fine jewelry, announced today that it has regained compliance with Nasdaq's minimum bid price...
Charles & Colvard Is A Growth ESG Company Trading Below Book
Charles & Colvard's lab grows precious stones known as moissanite. The majority of sales are online. It's trading at 71% of tangible book value which is mostly inventory and cash. It trades for $1.04 but has $0.47 in cash and...
Charles & Colvard, Ltd. (CTHR) CEO Don O'Connell on Q1 2021 Results - Earnings Call Transcript
Charles & Colvard, Ltd. (CTHR) CEO Don O'Connell on Q1 2021 Results - Earnings Call Transcript
Why Charles & Colvard (CTHR) Stock is a Compelling Investment Case
Silver Ring Value Partners recently released its Q3 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 6.9% for the last 12 months (net), underperforming its benchmark, the Russell 3000 Index which...
Fundamentals of behavioral finance: Loss aversion bias - InvestmentNews
Why clients value avoiding losses more than winning gains.
Gateway Investment Advisers LLC Has $482,000 Holdings in Charles River Laboratories Intl. Inc (NYSE:CRL)
Gateway Investment Advisers LLC lessened its holdings in shares of Charles River Laboratories Intl. Inc (NYSE:CRL) by 3.8% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor...
Pacer Advisors Inc. Buys New Stake in Charles River Laboratories Intl. Inc (NYSE:CRL)
Pacer Advisors Inc. bought a new stake in Charles River Laboratories Intl. Inc (NYSE:CRL) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 11,400...
Cancer screenings cancelled after fresh incident at Lucas Heights nuclear facility
A fault at Australia’s only nuclear medical facility leads to shortages of isotope crucial for diagnosing a variety of conditions
Source: https://incomestatements.info
Category: Stock Reports